CHICAGO-Directly engaging and recruiting patients online using social media will allow broader participation in cancer genomics research and hasten clinical advances, according to researchers at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 3-7 in Chicago (abstract LBA1519).
Advertisement
There is already evidence that a Mediterranean diet can help reduce chances of developing cancer in the first place, as well as protect against heart disease.
United Kingdom trial lead Dr Sara Erridge said, “Our important study showed that giving temozolomide chemotherapy after radiotherapy delays progression and significantly improves survival for this group of patients”. Mack added that liquid biopsies would be useful particularly when assessing patients during the course of diseases.
Professor Johann de Bono, head of drug development at the Institute of Cancer Research, London, and the Royal Marsden NHS Foundation Trust, agreed it was an “exciting time in the field” with “major benefits for patients”.
“Our study also demonstrates that statins could be a valuable addition to breast cancer treatment, and that this warrants investigation in clinical trials”.
Incidence of each aggressive therapy was remarkably similar across all five cancer types, said Chen.
The study may pave the way for new and more effective breast cancer therapy in the future.
“It should therefore become the new standard of care”.
Antonia’s combination approach centres on a group of immunotherapy treatments called checkpoint inhibitors, some of which release the “brakes” on cancer-killing immune cells. Rates of use ranged from approximately 6 percent in pancreatic cancer to 21 percent in lung cancer.
“This will be the largest study that’s ever tested the impact of weight loss on cancer – any form of cancer”.
This therapeutic option delivers chemotherapy directly to cancer cells, without having to wend its way through the bloodstream, noted Dr. Linus Chuang.
Study investigators also analyzed treatment trends before 2012 and between the first quarter of 2012 and the fourth quarter of 2014.
Some 93 percent of the women in the letrozole group were alive after five years, compared with 94 percent in the control group.
“Aromatase inhibitors do not have all the side effects of tamoxifen and overall are much better tolerated than tamoxifen”, explained one breast cancer expert, Dr. Stephanie Bernik.
“Outcomes for lung cancers have been very poor for a long time, so at Cancer Research UK we’re dramatically increasing the amount we’re spending on research in this area”.
However, more research will likely be needed before such treatments are used widely on the NHS. Patients who received results over the phone also reported fewer barriers to accessing genetic counseling services than those who received results in person. BCI classified 20% of patients as low risk with a 15-year risk of metastatic recurrence of 1.5% indicating these women might not require additional endocrine therapy.
Global Positioning System should be prescribing exercise alongside drugs, surgery and radiotherapy, top doctors said.
Should screen use of young children be limited? . “It is the next best pill to treatment and it is free and has no side effects”, said Melinda Irwin from Yale University in the US.
Advertisement
Ibrance is for women with oestrogen receptor-positive breast cancer or HER2 negative breast cancer that has spread around the body.
